• Home
  • Search Results
  • Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo.

Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo.

Nucleic acids research (2011-01-20)
Samir E L Andaloussi, Taavi Lehto, Imre Mäger, Katri Rosenthal-Aizman, Iulian I Oprea, Oscar E Simonson, Helena Sork, Kariem Ezzat, Dana M Copolovici, Kaido Kurrikoff, Joana R Viola, Eman M Zaghloul, Rannar Sillard, Henrik J Johansson, Fatouma Said Hassane, Peter Guterstam, Julia Suhorutšenko, Pedro M D Moreno, Nikita Oskolkov, Jonas Hälldin, Ulf Tedebark, Andres Metspalu, Bernard Lebleu, Janne Lehtiö, C I Edvard Smith, Ulo Langel
ABSTRACT

While small interfering RNAs (siRNAs) have been rapidly appreciated to silence genes, efficient and non-toxic vectors for primary cells and for systemic in vivo delivery are lacking. Several siRNA-delivery vehicles, including cell-penetrating peptides (CPPs), have been developed but their utility is often restricted by entrapment following endocytosis. Hence, developing CPPs that promote endosomal escape is a prerequisite for successful siRNA implementation. We here present a novel CPP, PepFect 6 (PF6), comprising the previously reported stearyl-TP10 peptide, having pH titratable trifluoromethylquinoline moieties covalently incorporated to facilitate endosomal release. Stable PF6/siRNA nanoparticles enter entire cell populations and rapidly promote endosomal escape, resulting in robust RNAi responses in various cell types (including primary cells), with minimal associated transcriptomic or proteomic changes. Furthermore, PF6-mediated delivery is independent of cell confluence and, in most cases, not significantly hampered by serum proteins. Finally, these nanoparticles promote strong RNAi responses in different organs following systemic delivery in mice without any associated toxicity. Strikingly, similar knockdown in liver is achieved by PF6/siRNA nanoparticles and siRNA injected by hydrodynamic infusion, a golden standard technique for liver transfection. These results imply that the peptide, in addition to having utility for RNAi screens in vitro, displays therapeutic potential.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
8-Aminonaphthalene-1,3,6-trisulfonic acid disodium salt, BioReagent, suitable for fluorescence, ≥90% (CE)

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.